SCHEMBL9105067

SCHEMBL9105067

CC(=O)Nc1cc(-c2nc(C(=O)NCc3cccs3)c(-c3ccccc3Cl)o2)c(C)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2D6 P10635 3/20 0.46
CYP2C19 P33261 3/20 0.46
CYP2C9 P11712 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 4/20 0.40
HPGD P15428 6/20 0.39
HTT P42858 2/20 0.39
USP2 O75604 1/20 0.39
MAPT P10636 3/20 0.38
CYP3A4 P08684 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 3/20 0.38
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
GAA P10253 2/20 0.38
PKM P14618 1/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9109647 0.88 MAPT (0.43) ALDH1A1SMN1; SMN2HPGDHTTMAPT
SCHEMBL9104246 0.88 HSP90AB1 (0.46) ALDH1A1HPGDHTTMAPTKDM4E
SCHEMBL9890578 0.88 HPGD (0.47) ALDH1A1CYP1A2CYP2C19POLBHPGD
SCHEMBL9890577 0.85 MAPT (0.46) ALDH1A1SMN1; SMN2POLBHPGDHTT
SCHEMBL9104901 0.85 GAA (0.44) ALDH1A1CYP1A2CYP2C9HTTCYP3A4
SCHEMBL9109120 0.85 ALDH1A1 (0.47) ALDH1A1CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL9108437 0.84 PIK3C3 (0.42) ALDH1A1SMN1; SMN2HTTMAPTKDM4E
SCHEMBL9106485 0.84 PIK3C3 (0.38) ALDH1A1SMN1; SMN2HTTMAPTLMNA
SCHEMBL9108294 0.84 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HPGDHTTMAPT
SCHEMBL9888733 0.84 PIK3C3 (0.38) ALDH1A1SMN1; SMN2HTTMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859768-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-10-14 US disclosed
US-8859768-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-10-14 US disclosed
US-20120142732-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-06-07 US disclosed
WO-2012021615-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142732-A1 HETEROARYLS AND USES THEREOF PIK3R4, PIK3C2B, PIK3R1 ALDH1A1 1905/4885CYP1A2 1443/4885CYP2D6 2448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.